Company: SMNR
Filing Date: 2025-05-16
Form Type: 10-Q
Source: 0001213900-25-044889
Chunk: 131

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-05-16
Form: 10-Q
Item: Part I, Item 4
Chunk 131
---
 Description of Exhibit
  
    31.1**
     
    Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  
    31.2**
     
    Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
  
    32.1***
     
    Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
  
    32.2***
     
    Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
  
    101.INS**
     
    Inline XBRL Instance Document.
  
    101.SCH**
     
    Inline XBRL Taxonomy Extension Schema Document.
  
    101.CAL**
     
    Inline XBRL Taxonomy Extension Calculation Linkbase Document.
  
    101.DEF**
     
    Inline XBRL Taxonomy Extension Definition Linkbase Document.
  
    101.LAB**
     
    Inline XBRL Taxonomy Extension Labels Linkbase Document.
  
    101.PRE**
     
    Inline XBRL Taxonomy Extension Presentation Linkbase Document.
  
    104
     
    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

    **
    Filed herein.

    ***
    Furnished herein.

39

Part
III. SIGNATURES

Pursuant to the requirements of Securities Exchange
Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

    Date: May 16, 2025
    DENALI CAPITAL ACQUISITION CORP.

    By:
    /s/ Lei Huang

    Chief Executive